# Haldol Decanoate

NDC: 50458-253
Generic name: Haloperidol Decanoate
Labeler / Manufacturer: Janssen Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAMUSCULAR
Marketing started: 19860114
Marketing ended: 20270531
FDA application: NDA018701

## Active ingredients

- HALOPERIDOL DECANOATE: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50458-253"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50458-253
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=af0159a8-dff5-449a-aa2b-a0c430081e21